BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23911682)

  • 21. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
    Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
    Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
    Dalbagni G
    Eur Urol; 2010 May; 57(5):849. PubMed ID: 19524355
    [No Abstract]   [Full Text] [Related]  

  • 24. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
    Cai T; Tiscione D; Verze P; Pomara G; Racioppi M; Nesi G; Barbareschi M; Brausi M; Gacci M; Luciani LG; Liguori G; Gontero P; Campodonico F; Simonato A; Boddi V; Di Stasi SM; Colombo R; Serretta V; Carmignani G; Malossini G; Altieri V; Carini M; Terrone C; Bassi P; Montorsi F; Ficarra V; Selli C; Mirone V; Bartoletti R
    Urology; 2014 Nov; 84(5):1141-6. PubMed ID: 25239253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy.
    Dwivedi US; Kumar A; Das SK; Trivedi S; Kumar M; Sunder S; Singh PB
    Urol Oncol; 2009; 27(5):514-9. PubMed ID: 18639472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transurethral resection of the bladder tumour (TURBT) for non-muscle invasive bladder cancer: basic skills.
    Furuse H; Ozono S
    Int J Urol; 2010 Aug; 17(8):698-9. PubMed ID: 20649827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
    Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH
    PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
    Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of obturator nerve block during transurethral resection of lateral bladder wall tumors on the presence of detrusor muscle in tumor specimens and recurrence of the disease.
    Erbay G; Akyol F; Karabakan M; Celebi B; Keskin E; Hirik E
    Kaohsiung J Med Sci; 2017 Feb; 33(2):86-90. PubMed ID: 28137416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
    Mastroianni R; Brassetti A; Krajewski W; Zdrojowy R; Salhi YA; Anceschi U; Bove AM; Carbone A; De Nunzio C; Fuschi A; Ferriero M; Nacchia A; Pastore AL; Tema G; Tuderti G; Gallucci M; Simone G
    Eur Urol Focus; 2021 Nov; 7(6):1324-1331. PubMed ID: 32900676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
    Huguet J; Gaya JM; Sabaté S; Palou J; Villavicencio H
    Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer].
    Chen JC; Li T; Ning XH; Peng SH; Wang JY; Qi NN; Cai L; Gong K
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1124-7. PubMed ID: 27095782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer: factors resulting in pT0 radical cystectomy specimens.
    Mazaris E; Nafie S; Boustead G
    Int Braz J Urol; 2013; 39(3):364-70. PubMed ID: 23849584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
    Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A
    Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of very large superficial bladder tumours: a 10-year experience.
    Gupta SK; Parr NJ
    Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
    Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
    Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.